Publication | Closed Access

Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes

Streptozotocin-induced Mouse ModelMitophagyCognitive DeclineCell AutophagyAutoimmune DiseaseMedicineDiabetesAutophagyDiabetes MellitusPharmacologyCell BiologyCell SignalingRapamycin Pathway